Новости за 16.05.2016

Treasury yields rose Monday, rebounding sharply from a five-week low reached on Friday, as surging oil prices boosted inflation expectations, which are traditionally viewed as an important component of Treasury yields.

This father set up a trust for his kids — but one son wants more.

U.S. home-builder sentiment holds steady in May

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Apple is top advancer as Dow industrials race to 60-point gain

U.S. stocks opened slightly higher Monday as investors weighed weak economic data from China against a renewed push higher for oil prices . A steep drop in a reading of New York-area business conditions also weighed on sentiment, while the market got a boost from a flurry of mergers and acquisitions, most notably Pfizer Inc.'s proposed purchase of Anacor Pharmaceuticals . The S&P 500 was up 2 points, or 0.1%, to 2,047. The Dow Jones Industrial Average gained 10 points, or 0.1%, to 17,547 at the open. Читать дальше...

Aduro Biotech shares halted

Warren Buffett’s Berkshire Hathaway took a new stake in Apple during the first quarter, valued at about $1 billion as of March 31.

There’s not much in the way of meaty data to chew on this week, but the still-fresh reaction to Friday’s upbeat retail sales report in addition to a dozen quarterly updates from the likes of Wal-Mart and Target should keep investors looking for more clues from the retail sector.

Aduro Biotech Inc. shares were halted in pre-market trade Monda, after the company said its pancreatic cancer drug missed the primary endpoint in a phase 2b clinical trial. The therapy being tested was CRS-207 both alone and in combination with GVAX Pancreas and was intended for patients with the cancer who had unsuccessfully undergone two prior metastatic therapies. Aduro's chairman, Stephen Isaacs, called the findings "unexpected" given "the divergence of these data from the results of our... Читать дальше...

Warren Buffett's investment vehicle Berkshire Hathaway Inc.'s new investment in Apple Inc. could be worth about $181.2 million less than it was 6 1/2 weeks ago, at the end of the first quarter. Berkshire's 13F filing showed that it owned a new 9,811,747 stake in Apple as of March 31, when the stock closed at $108.99, or 20% above Friday's closing price of $90.52. The filing did not disclose at what prices the shares were bought. The volume-weighted average price of Apple's stock during the quarter was $99.59. At that price... Читать дальше...

Magnitude 5.6 quake recorded north of Tokyo: NHK

Empire State index turns negative in May

Wal-Mart Stores Inc and McKesson Corporation are partnering to source generic pharmaceuticals, the companies announced Monday. The agreement adds on to an existing long-term distribution agreement between the two companies and could lower the cost of pharmaceutical care, the press release states. Shares of Wal-Mart were down less than 1% Monday.

SandRidge Energy Inc. said Monday it has filed for a "pre-arranged" reorganization under Chapter 11 supported by an agreement with creditors that own more than two thirds of its $4.1 billion in funded debt obligations. The company, which was forced into bankruptcy by the prolonged slump in oil prices and now trades over-the-counter, said the support agreement includes a reserve-based lending facility and the conversion to equity of about $3.7 billion of other funded debt. The company's pro forma... Читать дальше...

Tribune shares extend premarket gain in wake of increased Gannett bid

Apple Inc.'s stock surged 2% in premarket trade Monday, after Warren Buffett's Berkshire Hathaway Inc. disclosed in a regulatory filing that it took a new 9.8 million share stake in the technology giant during the first quarter. That would represent about 0.2% of Apple's shares outstanding, according to FactSet data. Other moves Berkshire made include selling 99% of its stake in Procter & Gamble Co. to just 315,400 shares, trimming its stake in Wal-Mart Stores Inc. by 1.7% to 55.2 million shares. Читать дальше...

Apple's stock rises in premarket following disclosure of new Buffett stake

Allergan plc said Monday it had positive results in two trials of its Oculeve Intranasal Tear Neurostimulator, OCUN-OO9 and OCUN-010, after both met their primary endpoints. The company said it's now on track for a premarket submission for the device to the Food and Drug Administration in the second half of the year. The product is aimed at increasing tear production in patients with Dry Eye Disease due to decreased tear production. Chronic dry eye disease effects more than 25 million people... Читать дальше...

Gypsum Management and Supply set terms for its initial public offering, which the wallboard and suspended ceilings systems company said could raise up to $185.15 million. As part of the terms, the company expects to sell 7 million shares at an IPO price between $21 to $23. The underwriters will be granted options to buy an additional 1.05 million shares. The stock had been approved for listing on the New York Stock Exchange under the symbol "GMS." The lead underwriters of the IPO are Barclays and Credit Suisse. Читать дальше...

Gannett Co. Inc. on Monday raised its bid for Tribune Publishing Co. to $15 a share from $12.25, or a 99% premium over Tribune's closing price on April 22, the last trading day before Gannett made its original offer. The total value of the new offer is about $864 million, including the assumption of about $385 million of debt, as well as other liabilities, Gannett said in a statement. The news sent shares of Tribune, which rebuffed the original offer, up 27% in premarket trade. "Our increased... Читать дальше...

Tribune jumps 27% premarket as Gannett raises offer to $15 per share vs $12.25

Anacor Pharmaceuticals Inc.'s stock rocketed 53% in premarket trade Monday, after the maker of an eczema treatment agreed to be acquired by Pfizer Inc. in a deal valued at $5.2 billion. Under terms of the deal, Pfizer will pay $99.25 a share for each Anacor share outstanding, which represent a 55% premium to Monday's closing price of $64.03 for Anacor's stock. Pfizer expects the deal, which the drug giant anticipates will be completed in the third quarter of 2016, to slightly reduce adjusted earnings per share in 2017... Читать дальше...

Pfizer to buy Anacor in deal valued at $5.2 bln or $99.25 per share

Warren Buffett has offered financial help to fellow billionaire investor Dan Gilbert in his bid to buy Yahoo Inc. , CNBC reported on Monday. The Berkshire Hathaway chief executive was rumored on Friday to be backing a consortium that includes Gilbert, the Quicken Loans Inc. founder and Cleveland Cavaliers NBA franchise owner. Buffett confirmed to CNBC on Monday he would be happy to bankroll Gilbert if needed. "Yahoo is not the type of thing I'd ever be an equity partner in. I don't know the business and wouldn't know how to evaluate it... Читать дальше...